Ulrich Keilholz
About
Ulrich Keilholz is a scholar working on Oncology, Molecular Biology and Immunology.
According to data from OpenAlex, Ulrich Keilholz has authored 477 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 301 papers in Oncology, 169 papers in Molecular Biology and 145 papers in Immunology. Recurrent topics in Ulrich Keilholz's work include Immunotherapy and Immune Responses (126 papers), Cutaneous Melanoma Detection and Management (65 papers) and Lung Cancer Treatments and Mutations (60 papers). Ulrich Keilholz is often cited by papers focused on Immunotherapy and Immune Responses (126 papers), Cutaneous Melanoma Detection and Management (65 papers) and Lung Cancer Treatments and Mutations (60 papers). Ulrich Keilholz collaborates with scholars based in Germany, United States and France. Ulrich Keilholz's co-authors include Carmen Scheibenbogen, Alexander Schmittel, Eckhard Thiel, Reinhard Dummer, Axel Hauschild, Alexander M.M. Eggermont, Anne Letsch, Stefan Suciu, Dirk Schadendorf and Claus Garbe and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Ulrich Keilholz
454 papers receiving 15.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ulrich Keilholz Germany | 65 | 9.2k | 6.1k | 5.8k | 2.2k | 1.8k | 477 | 15.5k | ||
| Grant A. McArthur Australia | 74 | 15.0k 1.6× | 15.2k 2.5× | 3.8k 0.7× | 5.4k 2.5× | 3.1k 1.8× | 395 | 26.8k | ||
| Michele Maio Italy | 66 | 11.4k 1.2× | 7.3k 1.2× | 6.9k 1.2× | 3.3k 1.5× | 1.8k 1.0× | 376 | 18.5k | ||
| Michael Hummel Germany | 73 | 7.6k 0.8× | 3.6k 0.6× | 4.0k 0.7× | 1.2k 0.6× | 1.8k 1.0× | 461 | 18.5k | ||
| Sanjiv S. Agarwala United States | 48 | 6.1k 0.7× | 4.2k 0.7× | 2.5k 0.4× | 1.9k 0.9× | 675 0.4× | 209 | 9.7k | ||
| John B.A.G. Haanen Netherlands | 72 | 13.9k 1.5× | 6.8k 1.1× | 10.8k 1.9× | 4.6k 2.1× | 2.0k 1.2× | 429 | 23.8k | ||
| Víctor G. Prieto United States | 65 | 8.8k 1.0× | 4.8k 0.8× | 2.1k 0.4× | 2.1k 1.0× | 1.5k 0.8× | 556 | 16.0k | ||
| Gavin P. Dunn United States | 45 | 8.4k 0.9× | 4.2k 0.7× | 8.9k 1.6× | 1.8k 0.8× | 1.9k 1.1× | 136 | 16.4k | ||
| Achim A. Jungbluth United States | 76 | 10.1k 1.1× | 7.8k 1.3× | 9.9k 1.7× | 3.6k 1.7× | 1.7k 1.0× | 285 | 20.9k | ||
| Rosemarie Mick United States | 72 | 6.2k 0.7× | 3.5k 0.6× | 3.2k 0.6× | 2.6k 1.2× | 2.1k 1.2× | 265 | 14.4k | ||
| Paolo A. Ascierto Italy | 75 | 18.1k 2.0× | 11.4k 1.9× | 7.1k 1.2× | 3.5k 1.6× | 2.5k 1.4× | 757 | 25.2k |
Countries citing papers authored by Ulrich Keilholz
Since
Specialization
Citations
This map shows the geographic impact of Ulrich Keilholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Keilholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Keilholz more than expected).
Fields of papers citing papers by Ulrich Keilholz
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ulrich Keilholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Keilholz. The network helps show where Ulrich Keilholz may publish in the future.
Co-authorship network of co-authors of Ulrich Keilholz
This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Keilholz. A scholar is included among the top collaborators of Ulrich Keilholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Keilholz. Ulrich Keilholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Schneider, F, Haotian Chen, Uwe Pelzer, et al.. (2025). The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients. European Journal of Cancer. 234. 116189–116189.
2.
Keilholz, Ulrich, et al.. (2025). A combined mathematical and experimental approach reveals the drivers of time-of-day drug sensitivity in human cells. Communications Biology. 8(1). 491–491.
3.
Eich, Marie‐Lisa, Georg Hilfenhaus, Bernhard Ralla, et al.. (2024). Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer. Urology Case Reports. 57. 102879–102879.
4.
Schmal, Christoph, Sébastien De Landtsheer, Anna‐Marie Finger, et al.. (2024). Time-of-day effects of cancer drugs revealed by high-throughput deep phenotyping. Nature Communications. 15(1). 7205–7205.
5.
Rieke, Damian, Manuela Benary, Peter Horak, et al.. (2023). Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts.. Journal of Clinical Oncology. 41(16_suppl). 3066–3066.
6.
Fayette, Jérôme, Lisa Licitra, Kevin J. Harrington, et al.. (2023). 854O INTERLINK-1: Phase III study of cetuximab (CTX) ± monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on/after platinum chemotherapy (CT) and previously treated with an immune checkpoint inhibitor (ICI). Annals of Oncology. 34. S554–S555.
7.
Neumann, Christopher, F Schneider, Georg Hilfenhaus, et al.. (2023). Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade. Cancers. 15(8). 2367–2367.
8.
Neumann, Christopher, F Schneider, Georg Hilfenhaus, et al.. (2023). Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade. Journal of Clinical Medicine. 12(11). 3656–3656.
9.
Steffen, Claudius, Simon Schallenberg, Mihnea P. Dragomir, et al.. (2023). Spatial heterogeneity of tumor cells and the tissue microenvironment in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 137(4). 379–390.
10.
Sachse, Christoph, Susen Burock, Ulrich Keilholz, et al.. (2022). Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis. Oncogene. 41(39). 4446–4458.
11.
Liebs, Sandra, Frederick Klauschen, Moritz Schütte, et al.. (2021). Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities. Oncogene. 40(33). 5204–5212.
12.
Klinghammer, Konrad, Jan-Dirk Raguse, Andreas E. Albers, et al.. (2017). Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer. International Journal of Cancer. 141(6). 1215–1221.
13.
Bonner, James A., Ricard Mesı́a, J. Giralt, et al.. (2017). p16, HPV, and Cetuximab: What Is the Evidence?. The Oncologist. 22(7). 811–822.
14.
Eggermont, Alexander M.M., Stefan Suciu, Alessandro Testori, et al.. (2012). Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma. Journal of Clinical Oncology. 30(31). 3810–3818.
15.
Tinhofer, Ingeborg, Konrad Klinghammer, Wilko Weichert, et al.. (2011). Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment. Clinical Cancer Research. 17(15). 5197–5204.
16.
Frey, Dietmar, Vânia Coelho, Ulf Petrausch, et al.. (2008). Surface Expression of gpA33 is Dependent on Culture Density and Cell-Cycle Phase and is Regulated by Intracellular Traffic Rather than Gene Transcription. Cancer Biotherapy and Radiopharmaceuticals. 23(1). 65–73.
17.
Vantomme, Valérie, Dirk Gheysen, Claudine Bruck, et al.. (2004). Immunologic Analysis of a Phase I/II Study of Vaccination with MAGE-3 Protein Combined with the AS02B Adjuvant in Patients with MAGE-3-Positive Tumors. Journal of Immunotherapy. 27(2). 124–135.
18.
Keilholz, Ulrich, Jeffrey S. Weber, James H. Finke, et al.. (2002). Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy. Journal of Immunotherapy. 25(2). 97–138.
19.
Max, Nicole, et al.. (2001). Nested Quantitative Real Time PCR for Detection of Occult Tumor Cells. Recent results in cancer research. 158. 25–31.
20.
Nagorsen, Dirk, Ulrich Keilholz, Licia Rivoltini, et al.. (2000). Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.. PubMed. 60(17). 4850–4.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Grant A. McArthur Breakdown of academic impact, for papers by Michele Maio Breakdown of academic impact, for papers by Michael Hummel Breakdown of academic impact, for papers by Sanjiv S. Agarwala Breakdown of academic impact, for papers by John B.A.G. Haanen Breakdown of academic impact, for papers by Víctor G. Prieto Breakdown of academic impact, for papers by Gavin P. Dunn Breakdown of academic impact, for papers by Achim A. Jungbluth Breakdown of academic impact, for papers by Rosemarie Mick Breakdown of academic impact, for papers by Paolo A. Ascierto